Skip to Main content Skip to Navigation
Journal articles

Angiotensin II Receptor Blockers (ARBs Antihypertensive Agents) Increase Replication of SARS-CoV-2 in Vero E6 Cells

Abstract : Several comorbidities, including hypertension, have been associated with an increased risk of developing severe disease during SARS-CoV-2 infection. Angiotensin II receptor blockers (ARBs) are currently some of the most widely-used drugs to control blood pressure by acting on the angiotensin II type 1 receptor (AT1R). ARBs have been reported to trigger the modulation of the angiotensin I converting enzyme 2 (ACE2), the receptor used by the virus to penetrate susceptible cells, raising concern that such treatments may promote virus capture and increase their viral load in patients receiving ARBs therapy. In this in vitro study, we reviewed the effect of ARBs on ACE2 and AT1R expression and investigated whether treatment of permissive ACE2+/AT1R+ Vero E6 cells with ARBs alters SARS-CoV-2 replication in vitro in an angiotensin II-free system. After treating the cells with the ARBs, we observed an approximate 50% relative increase in SARS-CoV-2 production in infected Vero E6 cells that correlates with the ARBs-induced up-regulation of ACE2 expression. From this data, we believe that the use of ARBs in hypertensive patients infected by SARS-CoV-2 should be carefully evaluated.
Complete list of metadata

https://hal-amu.archives-ouvertes.fr/hal-03300025
Contributor : Isabelle Combe Connect in order to contact the contributor
Submitted on : Monday, July 26, 2021 - 6:14:27 PM
Last modification on : Tuesday, October 19, 2021 - 10:50:35 PM

Links full text

Identifiers

Collections

Citation

Gabriel Augusto Pires de Souza, Ikram Omar Osman, Marion Le Bideau, Jean-Pierre Baudoin, Rita Jaafar, et al.. Angiotensin II Receptor Blockers (ARBs Antihypertensive Agents) Increase Replication of SARS-CoV-2 in Vero E6 Cells. Frontiers in Cellular and Infection Microbiology, Frontiers, 2021, 11, ⟨10.3389/fcimb.2021.639177⟩. ⟨hal-03300025⟩

Share

Metrics

Record views

17